HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate Pushes Acid-Neutralizing Toothpaste As Emerging Market Driver

This article was originally published in The Tan Sheet

Executive Summary

The firm looks for the launch of the “breakthrough” Colgate Superior Anti-Cavity with Neutrasucar to strengthen its foothold in Brazil, where it commands 71% of the toothpaste market. Colgate says the product is ideal for emerging markets, where tooth decay is a major public health problem.

You may also be interested in...



Colgate Offers 'Anti-Aging' Toothpaste In China, Ready For 'Prolonged' Coronavirus

Colgate expects a ‘modest negative impact’ from the coronavirus on its first quarter results, but it made contingency plans for longer-term impact. In a presentation at the CAGNY conference, CEO Noel Wallace discussed a new anti-aging toothpaste in China and the latest iteration of Colgate Optic White in the US.

Colgate “Superior” Anti-Cavity Toothpaste Launching In Emerging Markets

Colgate-Palmolive CEO Ian Cook highlights innovations targeted to emerging markets, including a new toothpaste containing acid-neutralizing technology for advanced cavity prevention.

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124037

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel